NaxSwab OTC naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study

BETHESDA, Md., Dec. 1, 2022. Pocket Naloxone Corp., a startup pharmaceutical company with the vision of enhancing naloxone delivery, today announced positive results from its human pharmacokinetic (PK) study of its novel naloxone nasal swab NaxSwab....
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials